Short-Chain Fatty Acids and Neurodegeneration in Alzheimer's Disease: A Narrative Review
DOI:
https://doi.org/10.59141/-.v8i1.498Keywords:
short chain fatty acids, Alzheimer Disease, gut brain axis, neuroinflammation, microbiota dysbiosisAbstract
Background: Alzheimer Disease remains the most prevalent cause of dementia worldwide, representing a major and escalating global health challenge. Objective: This study aims to examine the role of short chain fatty acids in the pathogenesis and progression of Alzheimer Disease within the framework of the microbiota gut brain axis. Methods: The research employed a qualitative design with a descriptive approach through a narrative literature study. Data were collected through systematic searches of peer reviewed scientific articles published between 2015 and 2026, focusing on gut microbiota dysbiosis, short chain fatty acids, neuroinflammation, amyloid pathology, and cognitive decline in Alzheimer Disease. Document analysis was conducted using thematic identification, data reduction, conceptual categorization, and inductive interpretation to generate a comprehensive synthesis of the evidence. Results: The findings indicate that Alzheimer Disease is consistently associated with reduced abundance of short chain fatty acid producing bacteria and altered circulating and fecal short chain fatty acid profiles, which are linked to impaired blood brain barrier integrity, microglial activation, increased neuroinflammation, amyloid beta accumulation, and tau pathology. Mechanistic insights demonstrate that short chain fatty acids regulate inflammatory signaling pathways, epigenetic modulation, mitochondrial bioenergetics, and metabolic homeostasis. Conclusion: In conclusion, short chain fatty acids function as key metabolic mediators in Alzheimer Disease and represent promising targets for preventive and therapeutic strategies, contributing to a systems biology perspective and supporting microbiome based precision approaches in cognitive health management.
Downloads
References
Abdol Samat, H. N., Razali, N. N., Mahadzir, H., Tengku Muhammad, T. S., Ling, K. H., Mansor, N. I., & Abidin, S. Z. A. (2025). The interplay of inflammation and gut microbiota dysbiosis in Alzheimers disease: Mechanisms and therapeutic potential. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26188905
Abraham, D., & P, P. (2024). A methodological framework for descriptive phenomenological research. Western Journal of Nursing Research, 47, 125–134. https://doi.org/10.1177/01939459241308071
Al Msalmeh, Y. (2025). Gut microbiota alterations and their impact on Alzheimers disease progression: Review article. The Egyptian Journal of Hospital Medicine. https://doi.org/10.21608/ejhm.2025.466074
Baillie, J. (2019). Commentary: An overview of the qualitative descriptive design within nursing research. Journal of Research in Nursing, 25, 458–459. https://doi.org/10.1177/1744987119881056
Bandaranayake, P. (2024). Application of grounded theory methodology in library and information science research: An overview. Sri Lanka Library Review. https://doi.org/10.4038/sllr.v38i2.70
Bashir, B., Gulati, M., Vishwas, S., Gupta, G., Dhanasekaran, M., Paudel, K., Chellappan, D., Anand, K., Negi, P., Singh, P. K., Rajput, A., Dua, K., & Singh, S. (2025). Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2025.102689
Belotto, M. (2018). Data analysis methods for qualitative research: Managing the challenges of coding, interrater reliability, and thematic analysis. The Qualitative Report. https://doi.org/10.46743/2160-3715/2018.3492
Bingham, A. (2023). From data management to actionable findings: A five phase process of qualitative data analysis. International Journal of Qualitative Methods, 22. https://doi.org/10.1177/16094069231183620
Bswald, L., Wenderlein, J., Bachmann, M., Zeyner, A., Neuhaus, K., Schfer, F., Imhof, A., Lahiri, S., Gruetzke, J., & Popper, B. (2025). Fibre supplementation alters the gastrointestinal microbiome, the microbial metabolites and indicators of neurodegeneration in a mouse model of Alzheimers disease. Scientific Reports. https://doi.org/10.1038/s41598-025-20986-8
Dandamudi, B. J., Dimaano, K. A. M., Shah, N., AlQassab, O., Al-Sulaitti, Z., Nelakuditi, B., & Mohammed, L. (2024). Neurodegenerative disorders and the gut-microbiome-brain axis: A literature review. Cureus. https://doi.org/10.7759/cureus.72427
de Rijke, T. J., Doting, M. H. E., van Hemert, S., de Deyn, P. D., van Munster, B. C., Harmsen, H., & Sommer, I. (2022). A systematic review on the effects of different types of probiotics in animal Alzheimers disease studies. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.879491
Faulin, T. E. S., & Estadella, D. (2023). Alzheimer’s disease and its relationship with the microbiota-gut-brain axis. Arquivos de Gastroenterologia. https://doi.org/10.1590/S0004-2803.202301000-17
Fife, S., & Gossner, J. (2024). Deductive qualitative analysis: Evaluating, expanding, and refining theory. International Journal of Qualitative Methods, 23. https://doi.org/10.1177/16094069241244856
Granikov, V., Hong, Q., Crist, E., & Pluye, P. (2020). Mixed methods research in library and information science: A methodological review. Library & Information Science Research. https://doi.org/10.1016/j.lisr.2020.101003
Guo, B. B., Zhang, J., Zhang, W., Chen, F., & Liu, B. (2023). Gut microbiota-derived short chain fatty acids act as mediators of the gutbrain axis targeting age-related neurodegenerative disorders: A narrative review. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408398.2023.2272769
Jagodic, A., Krek, A., Schleicher, L. M. S., & Batii, L. (2025). Microbiome dysbiosis as a driver of neurodegeneration: Insights into Alzheimer’s and Parkinson’s diseases. Gastrointestinal Disorders. https://doi.org/10.3390/gidisord7020028
Ji, X., Wang, J., Lan, T., Zhao, D., & Xu, P. (2025). Gut microbial metabolites and the braingut axis in Alzheimers disease: A review. Biomolecules & Biomedicine. https://doi.org/10.17305/bb.2025.12921
Jimenez, S., Berbegal‐Mirabent, J., & De La Torre, R. (2024). How do university libraries contribute to the research process?. The Journal of Academic Librarianship. https://doi.org/10.1016/j.acalib.2024.102930
Kalkan, A. E., BinMowyna, M., Raposo, A., Ahmad, M. F., Ahmed, F., Otayf, A. Y., Carrascosa, C., Saraiva, A., & Karav, S. (2025). Beyond the gut: Unveiling butyrates global health impact through gut health and dysbiosis-related conditions: A narrative review. Nutrients. https://doi.org/10.3390/nu17081305
Kalpokaite, N., & Radivojevic, I. (2018). Demystifying qualitative data analysis for novice qualitative researchers. The Qualitative Report. https://doi.org/10.46743/2160-3715/2019.4120
Killingsworth, J., Sawmiller, D., & Shytle, R. (2021). Propionate and Alzheimer’s disease. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2020.580001
Kuehn, J. F., Zhang, Q., Heston, M. B., Kang, J. W., Harding, S., Davenport-Sis, N. J., Kerby, R. L., Schiffmann, E. C., Wheeler, J. L., Clements, E., Shankar, S., Mickol, A., Zemberi, J., Chow, H., Zhang, E., Harpt, J., Mushtaque, A., Yoo, M., Cook, A., Carlsson, C., Johnson, S., Asthana, S., Zetterberg, H., Blennow, K., Ulland, T. K., Bendlin, B., & Rey, F. E. (2025). Fecal levels of shortchain fatty acids and prominent bacterial taxa involved in their production are inversely associated with amyloidpositive status. Alzheimers & Dementia. https://doi.org/10.1002/alz70856_098071
Lista, S., Munaf, A., Caraci, F., Imbimbo, C., Emanuele, E., Minoretti, P., Pinto-Fraga, J., Merino-Pas, M., Crespo-Escobar, P., Lopez-Ortiz, S., Monteleone, G., Imbimbo, B., & Santos-Lozano, A. (2025). Gut microbiota in Alzheimers disease: Understanding molecular pathways and potential therapeutic perspectives. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2025.102659
Mafe, A. N., & Bsselberg, D. (2025). Could a Mediterranean diet modulate Alzheimers disease progression? The role of gut microbiota and metabolite signatures in neurodegeneration. Foods. https://doi.org/10.3390/foods14091559
Marizzoni, M., Coppola, L., Festari, C., Luongo, D., Salamone, D., Naviglio, D., Soricelli, A., Mirabelli, P., Salvatore, M., Cattaneo, A., & Frisoni, G. B. (2025). Circulating short chain fatty acids in Alzheimers disease: A cross-sectional observational study. Journal of Alzheimers Disease. https://doi.org/10.1177/13872877251337773
Noble, N., Gold, A., & Zhu, J. (2025). The impact of nutritional and exercise interventions on Alzheimer’s disease pathophysiology via modulation of the microbiota-gut-brain-axis. Nutritional Neuroscience. https://doi.org/10.1080/1028415X.2025.2565706
Oki, J., & Dini, M. (2025). Microbiota and Alzheimer’s disease: Toward new clinical approaches. Medicinski Podmladak. https://doi.org/10.5937/mp76-60520
Oso, T. A., Ahmed, M. M., Okesanya, O., Adebayo, U. O., Obadeyi, K. B., Othman, Z., & Lucero-Prisno, D. (2025). Exploring the gut-brain-microbiome axis in Alzheimer’s disease: Integrating metagenomics, metabolomics, and artificial intelligence for next-generation biomarker discovery. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251407700
Pavithra, R., Kanimozhi, N., Sonali, L., Suneetha, C., & Sukumar, M. (2025). Unveiling role of gut microbiota in Alzheimer’s disease: Mechanisms, challenges and future perspectives. Current Alzheimer Research. https://doi.org/10.2174/0115672050403066250904112611
Pfaffinger, J. M., Hays, K. E., Seeley, J., Babu, P. R., & Ryznar, R. (2025). Gut dysbiosis as a potential driver of Parkinson’s and Alzheimer’s disease pathogenesis. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2025.1600148
Pratt, M. (2025). On the evolution of qualitative methods in organizational research. Annual Review of Organizational Psychology and Organizational Behavior. https://doi.org/10.1146/annurev-orgpsych-111722-032953
Qian, X., Xie, R. Y., Liu, X., Chen, S., & Tang, H. (2022). Mechanisms of short-chain fatty acids derived from gut microbiota in Alzheimer’s disease. Aging and Disease. https://doi.org/10.14336/ad.2021.1215
Samat, H. N. A., Razali, N. N., Mahadzir, H., Muhammad, T. S. T., Ling, K. H., Mansor, N. I., & Abidin, S. Z. (2025). The interplay of inflammation and gut-microbiota dysbiosis in Alzheimer’s disease: Mechanisms and therapeutic potential. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26188905
Togia, A., & Malliari, A. (2017). Research methods in library and information science. https://doi.org/10.5772/intechopen.68749
Vila‐Henninger, L., Dupuy, C., Van Ingelgom, V., Caprioli, M., Teuber, F., Pennetreau, D., Bussi, M., & Gall, C. (2022). Abductive coding: Theory building and qualitative reanalysis. Sociological Methods & Research, 53, 968–1001. https://doi.org/10.1177/00491241211067508
Xu, G., An, Y., Du, Y., Cao, Z., Zheng, J., Wang, J., Li, T., Lei, X., & Lu, Y. (2025). Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimers disease. iMetaOmics. https://doi.org/10.1002/imo2.70020
Xue, D., Hu, X., Li, R., Sun, T., Qian, S., Chu, F., Gao, H., Li, F., & Cai, B. (2026). Plant derived bioactive compounds modulate the gut microbiota in Alzheimer’s disease: Metabolite signaling, neuroimmune circuits, and systems level regulation. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.157919
Yang, Y., Wang, Q., Wang, Z., Wang, Y., Liu, B., Zhang, Y., Mao, X., & Sun, H. (2025). The role of fatty acids in neurodegenerative diseases: Mechanistic insights and therapeutic strategies. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2025.100944
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Komang Trisna Sumadewi, Dewa Ayu Agung Alit Suka Astini, Luh Gde Evayanti, Ida Ayu Laxmi Ananda Dewi Manuaba, Ni Made Gita Kusuma Dewi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
